High convergence of molecular diagnostics and big data analytics will enable predictive analytical capabilities for diagnostic platforms. Several in vitro diagnostic (IVD) companies are expanding their product portfolios to include liquid biopsy and companion diagnostics (CDx) in their long-term strategies. Our research coverage includes tissue diagnostics, liquid biopsy, digital pathology and pre-natal diagnostics and biomarkers for combination therapies.
Know anyone building innovative solutions that belong in this 'Molecular Diagnostics & Companion Diagnostics'?
This is a great opportunity to explore and enhance great arguments in the field of Personalized Medicine. This will be a great occasion to meet Delegates, keynote speakers, students from universities, scientists, professors, Cardiologists, Nurses, Pharmacists, Nano technologists, directors, and Business delegates at the webinar to exchange scientific ideas and experiences in a distinctive environment and share your thoughts and suggestions to all the participants.
ONCOMPASS™ Full is a premier molecular diagnostic and therapeutic information service. It includes a cutting edge molecular diagnostic of up to 60 therapeutically relevant genes from the tumor, using …
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our